UPClytics
View all cases

UPC CFI 3290/2026

Sep 14, 2026·EP1732548 +1 more · METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS

Case details
Status
Written Phase
Action
Revocation
Category
Main revocation action
Parties
Claimants
Representatives
  • Daniel Hoppe
Respondents
Representatives
Division
Milan CD
Technology
  • Chemistry
    Pharmaceuticals
Language
English
EPO Opposition
  • Synthon B.V.Admissible2012-03-07
  • neuraxpharm Arzneimittel GmbH & Co. KG2012-03-08
  • neuraxpharm Arzneimittel GmbHAdmissible2012-03-08
  • Actavis Group PTC ehfAdmissible2013-12-05
  • Synthon B.V.Admissible2013-12-06
  • neuraxpharm Arzneimittel GmbHAdmissible2013-12-06
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Patent revokedMedian days to first decision
All UPC37% (34/91)124
Milan CDLockedLocked
Judge Andrea PostiglioneLockedLocked
Judge Marije KnijffLockedLocked

At the UPC: STADAPHARM GmbH (10 cases)·Merz Pharmaceuticals LLC (7 cases)

Related cases
Document titleDatePublic
Communication2026-10-14Not public
Receipt2026-10-13Not public
Cover sheet2026-10-13Not public
Further pleadings2026-10-13Not public
Publication2026-10-05Not public
Communication2026-10-05Not public
Service Receipt/Service Document2026-10-05Not public
Receipt2026-09-21Not public
Cover sheet2026-09-21Not public
Communication2026-09-17Not public